TrialLeukemia & lymphoma2024

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia.

Jennifer Marvin-Peek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.